OrsoBio Announces Oversubscribed $67 Million Series B Financing to Accelerate Mitochondrial Protonophore Portfolio Targeting Obesity and Associated Disorders by Seini Moimoi | Sep 6, 2024 | Portfolio News
Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor by Seini Moimoi | Aug 26, 2024 | Portfolio News
BioAge Appoints Former GSK CEO Jean-Pierre Garnier as Chair of Its Board of Directors by Seini Moimoi | Aug 22, 2024 | Portfolio News
89bio Appoints Francis Sarena as Chief Operating Officer by Seini Moimoi | Aug 7, 2024 | Portfolio News
BioAge Announces First Patient Dosed in the STRIDES Phase 2 Clinical Trial Evaluating Azelaprag as a Novel Treatment for Obesity in Combination with Tirzepatide by Seini Moimoi | Jul 29, 2024 | Portfolio News
